These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35754286)

  • 1. A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.
    Al Shehri A; Al-Asmi A; Al Salti AM; Almadani A; Hassan A; Bamaga AK; Cupler EJ; Al-Hashel J; Alabdali MM; Alanazy MH; Noori S
    J Neuromuscul Dis; 2022; 9(5):661-673. PubMed ID: 35754286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Group Consensus on early diagnosis and management of infantile-onset pompe disease in the Gulf Region.
    Al-Hassnan Z; Hashmi NA; Makhseed N; Omran TB; Al Jasmi F; Teneiji AA
    Orphanet J Rare Dis; 2022 Oct; 17(1):388. PubMed ID: 36303251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know.
    Jastrzębska A; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2023; 57(2):143-150. PubMed ID: 36478346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is early detection of late-onset Pompe disease a pneumologist's affair? A lesson from an Italian screening study.
    Confalonieri M; Vitacca M; Scala R; Polverino M; Sabato E; Crescimanno G; Ceriana P; Antonaglia C; Siciliano G; Ring N; Zacchigna S; Salton F; Vianello A;
    Orphanet J Rare Dis; 2019 Mar; 14(1):62. PubMed ID: 30832705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
    Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
    Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
    Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
    J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic criteria for late-onset (childhood and adult) Pompe disease.
    American Association of Neuromuscular & Electrodiagnostic Medicine
    Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis recommendations for late-onset Pompe disease].
    Brito-Avô L; Alves JD; Costa JM; Valverde A; Santos L; Araújo F; Aguiar P; Marinho A; Oliveira A; Gomes D
    Acta Med Port; 2014; 27(4):525-9. PubMed ID: 25203965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus treatment recommendations for late-onset Pompe disease.
    Cupler EJ; Berger KI; Leshner RT; Wolfe GI; Han JJ; Barohn RJ; Kissel JT;
    Muscle Nerve; 2012 Mar; 45(3):319-33. PubMed ID: 22173792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale.
    Hundsberger T; Schoser B; Leupold D; Rösler KM; Putora PM
    J Neurol; 2019 Aug; 266(8):2010-2017. PubMed ID: 31104135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
    Meznaric M; Fumic K; Leonardis L
    J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
    Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A database for screening and registering late onset Pompe disease in Turkey.
    Gokyigit MC; Ekmekci H; Durmus H; Karlı N; Koseoglu E; Aysal F; Kotan D; Ali A; Koytak PK; Karasoy H; Yaman A; Sengun İS; Sayin R; Tiftikcioglu BI; Soysal A; Tutkavul K; Bayrak AO; Kısabay A; Elci MA; Yayla V; Yılmaz İA; Ozdamar SE; Erdogan C; Tasdemir N; Serdaroglu Oflazer P;
    Neuromuscul Disord; 2018 Mar; 28(3):262-267. PubMed ID: 29395671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.
    ; Al Jasmi F; Al Jumah M; Alqarni F; Al-Sanna'a N; Al-Sharif F; Bohlega S; Cupler EJ; Fathalla W; Hamdan MA; Makhseed N; Nafissi S; Nilipour Y; Selim L; Shembesh N; Sunbul R; Tonekaboni SH
    BMC Neurol; 2015 Oct; 15():205. PubMed ID: 26471939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China.
    Zhao HH; Ma Z; Ying ZX; Niu FN; Luo MT; Wang Z; Cheng X; Zhang QQ; Niu Q
    Ann Transl Med; 2021 Dec; 9(24):1803. PubMed ID: 35071497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
    Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
    Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
    Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
    Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease.
    Gesquière-Dando A; Attarian S; Maues De Paula A; Pouget J; Salort-Campana E
    Muscle Nerve; 2015 Aug; 52(2):300-4. PubMed ID: 25703594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus.
    Fatehi F; Ashrafi MR; Babaee M; Ansari B; Beiraghi Toosi M; Boostani R; Eshraghi P; Fakharian A; Hadipour Z; Haghi Ashtiani B; Moravej H; Nilipour Y; Sarraf P; Sayadpour Zanjani K; Nafissi S
    Front Neurol; 2021; 12():739931. PubMed ID: 34621239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.